Internal Medicine, Infectious Disease · Brooklyn, NY
NPI
1588775183
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
506 6th St, East Pavilion 3rd Floor New York Methodist Hospital
Brooklyn, NY, 11215
Phone (718) 780-5246
Groups this clinician bills Medicare through
Medicare paid, 2024
$55K
643 services
Medicare patients, 2024
202
Average age 74
Drug cost, 2024
$1.5M
634 prescriptions
Company payments, 2025
$20.73
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Natalya Goldshteyn was code 99232 (hospital e&m - subsequent), 359 times for 122 patients. In total Natalya Goldshteyn billed 643 services in 11 codes, and Medicare paid $55K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 359 | 122 | $70.56 | $25K |
| 99222 Hospital E&M - Initial | Facility | 134 | 120 | $117.09 | $16K |
| 99214 Office E&M - Established | Facility | 73 | 40 | $77.36 | $5,647 |
| 99233 Hospital E&M - Subsequent | Facility | 31 | 17 | $106.69 | $3,307 |
| 99223 Hospital E&M - Initial | Facility | 18 | 17 | $156.60 | $2,819 |
| 99204 Office E&M - New | Facility | 14 | 14 | $100.81 | $1,411 |
By year: 2022 $42K for 453 services; 2023 $55K for 597 services; 2024 $55K for 643 services.
Medicare prescription drug claims, 2024
In 2024, the drug Natalya Goldshteyn prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 72 prescriptions and refills. In total Natalya Goldshteyn wrote 634 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 72 | 82 | 13 | $304K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 67 | 67 | Under 11 | $267K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 63 | 71 | Under 11 | $257K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 34 | 34 | Under 11 | $114K |
| Prezcobix Darunavir/Cobicistat | 28 | 28 | Under 11 | $70K |
| Juluca Dolutegravir/Rilpivirine | 28 | 29 | Under 11 | $99K |
| Stribild Elviteg/Cob/Emtri/Tenofo Disop | 24 | 24 | Under 11 | $101K |
| Amlodipine Besylate Generic | 20 | 28 | Under 11 | $59.72 |
| Valacyclovir Valacyclovir Hcl | 20 | 22 | Under 11 | $573 |
| Tivicay Dolutegravir Sodium | 17 | 17 | Under 11 | $40K |
| Metoprolol Succinate Generic | 13 | 19 | Under 11 | $75.58 |
| Atorvastatin Calcium Generic | 13 | 21 | Under 11 | $110 |
| Cefuroxime Cefuroxime Axetil | 13 | 13 | Under 11 | $286 |
| Darunavir Generic | 12 | 12 | Under 11 | $20K |
| Metformin Hcl Generic | 11 | 11 | Under 11 | $7.37 |
Brand drugs: 383 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Natalya Goldshteyn $20.73 ($20.73 in general payments such as food, travel and fees) from 1 company. The largest payer was Merck Sharp & Dohme LLC with $20.73.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 1 | $20.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.